Analysis and comparison of carboxyl esterase and trp channel expression in the skin of sensitive skin persons and atopic dermatitis patients

Analysis and comparison of carboxyl esterase and trp channel expression in the skin of sensitive skin persons and atopic dermatitis patients - Analysis and comparison of enzymes in the skin of sensitive skin persons and atopic dermatitis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021911

Enrollment

Registered

2016-04-15

Start date

2017-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atopic dermatitis

Interventions

skin biopsy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The atopic dermatitis patient assumes it the person who had a diagnosis in department of dermatology, Hamamatsu university school of medicine. We perform questionary survey over a telephone for 800-1000 volunteers about the physically unimpaired person with a sense stimulation sensitive person. We perform stinging examination for 180-190 people in hope of an examination. Based on stinging test result, we choose a subject.

Exclusion criteria

Exclusion criteria: 1. A person with remarkable bleeding tendency. 2. A pregnant woman. 3. The person who has difficulty in self-judgment for dementia. 4. The person whom it was judged a doctor to be in condition to be easy to be accompanied by complications when it enforced skin biopsy. 5. A person during an immunosuppressant, the adrenocorticosteroid whole body dosage.

Design outcomes

Primary

Measure	Time frame
The expression of carboxyl esterase and trp channel	—

Countries

Japan

Contacts

Public ContactMasahiro Aoshima

Hamamatsu university school of medicine Department of dermatology

maoshima@hama-med.ac.jp053-435-2303

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026